Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C15H20O2 |
| Molecular Weight | 232.3181 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C(O)=O)C1=CC=C(C=C1)C2CCCCC2
InChI
InChIKey=YTUMWOBUZOYYJQ-UHFFFAOYSA-N
InChI=1S/C15H20O2/c1-11(15(16)17)12-7-9-14(10-8-12)13-5-3-2-4-6-13/h7-11,13H,2-6H2,1H3,(H,16,17)
| Molecular Formula | C15H20O2 |
| Molecular Weight | 232.3181 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2739811
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2739811
Hexaprofen, a potent anti-inflammatory agent, is an inhibitor of platelet aggregation. Experiments on mice have shown that hexaprofen could reduce the quantity and size of Lewis lung carcinoma (LLC) tumor nodules.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:50:10 GMT 2025
by
admin
on
Wed Apr 02 07:50:10 GMT 2025
|
| Record UNII |
H2F4OV65RN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000083976
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
246-379-8
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
3490
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
24645-20-3
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL244138
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
71703
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
SUB08031MIG
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
C83751
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
DTXSID901030988
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
H2F4OV65RN
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |